# Geoffrey R. Oxnard

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/geoffrey-r-oxnard/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,236 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 77 |
| i10-index | 228 |
| Last Known Institution | Boston Medical Center |
| OpenAlex ID | https://openalex.org/A5045665778 |
| ORCID iD | 0000-0003-1054-8240 |
| Works | 1,014 |

## Researcher papers

Showing 12 of 19.

- [Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M](https://scholariq.org/papers/acquired-egfr-c797s-mutation-mediates-resistance-to-azd9291-in-non-small-cell/)
- [Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA](https://scholariq.org/papers/sensitive-and-specific-multi-cancer-detection-and-localization-using-methylation/)
- [Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review](https://scholariq.org/papers/circulating-tumor-dna-analysis-in-patients-with-cancer-american-society-of/)
- [Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/association-between-plasma-genotyping-and-outcomes-of-treatment-with-osimertinib/)
- [Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/efficacy-of-selpercatinib-in-i-ret-i-fusion-positive-non-small-cell-lung-cancer/)
- [Noninvasive Detection of Response and Resistance in <i>EGFR</i> -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA](https://scholariq.org/papers/noninvasive-detection-of-response-and-resistance-in-i-egfr-i-mutant-lung-cancer/)
- [<i>MET</i> Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent <i>MET</i> Genomic Amplification and c-Met Overexpression](https://scholariq.org/papers/i-met-i-exon-14-mutations-in-non-small-cell-lung-cancer-are-associated-with/)
- [Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib](https://scholariq.org/papers/assessment-of-resistance-mechanisms-and-clinical-implications-in-patients-with-i/)
- [Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer](https://scholariq.org/papers/rociletinib-in-i-egfr-i-mutated-non-small-cell-lung-cancer/)
- [Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation](https://scholariq.org/papers/acquired-resistance-to-egfr-tyrosine-kinase-inhibitors-in-egfr-mutant-lung/)
- [Prospective Validation of Rapid Plasma Genotyping for the Detection of<i>EGFR</i>and<i>KRAS</i>Mutations in Advanced Lung Cancer](https://scholariq.org/papers/prospective-validation-of-rapid-plasma-genotyping-for-the-detection-of-i-egfr-i/)
- [Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer](https://scholariq.org/papers/structural-biochemical-and-clinical-characterization-of-epidermal-growth-factor/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Boston Medical Center](https://scholariq.org/institutions/boston-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.